Aspartate-β-hydroxylase and hypoxia marker expression in head and neck carcinomas: implications for HPV-associated tumors.
Aspartate-β-hydroxylase
Head and neck cancer
Human papillomavirus
Hypoxia
Prognosis
Journal
Infectious agents and cancer
ISSN: 1750-9378
Titre abrégé: Infect Agent Cancer
Pays: England
ID NLM: 101276559
Informations de publication
Date de publication:
10 Jun 2024
10 Jun 2024
Historique:
received:
19
01
2024
accepted:
28
05
2024
medline:
11
6
2024
pubmed:
11
6
2024
entrez:
10
6
2024
Statut:
epublish
Résumé
A proportion of head and neck carcinomas (HNSCCs) are induced by high-risk human papillomaviruses (HPVs) and are associated with better patient outcomes compared to patients with HNSCCs related to tobacco and alcohol abuse. In the microenvironment of solid tumors, including HNSCCs, oxygen levels are often reduced, and a hypoxic state is induced. This can lead to a poor treatment response and a worse patient prognosis. One of the hypoxia-responsive genes is aspartate-β-hydroxylase (ASPH), whose activity promotes the growth, invasiveness, and metastasis of many types of solid tumors. In our study, HNSCC samples were analyzed for the expression of ASPH and selected endogenous hypoxia markers by real-time PCR and/or multiplex fluorescence immunohistochemistry. Except for the EPAS1 gene, which had higher mRNA expression in the HPV-negative group of HNSCC (p < 0.05), we found no other differences in the expression of the tested genes that were related to HPV status. On the contrary, a statistically significantly higher number of cells producing ASPH (p < 0.0001), HIF1A (p < 0.0001), GLUT1 (p < 0.0001), and MMP13 (p < 0.05) proteins were detected in the HPV-positive tumor group than in the HPV-negative sample group. All the evaluated markers, except for MMP9/13, were more abundant in the tumor parenchyma than in the tumor stroma. The Cox proportional hazard models showed that increased numbers of cells with GLUT1 and HIF1A protein expression were positive prognostic markers for overall and disease-specific survival in patients independent of HPV tumor status. The study examined HNSCC samples and found that elevated ASPH and hypoxia marker proteins, typically associated with poor prognosis, may actually indicate active HPV infection, the strongest prognostic factor in HNSCC patients. In cases where HPV status is uncertain, increased expression of HIF1A and GLUT1 can serve as positive prognostic factors.
Sections du résumé
BACKGROUND
BACKGROUND
A proportion of head and neck carcinomas (HNSCCs) are induced by high-risk human papillomaviruses (HPVs) and are associated with better patient outcomes compared to patients with HNSCCs related to tobacco and alcohol abuse. In the microenvironment of solid tumors, including HNSCCs, oxygen levels are often reduced, and a hypoxic state is induced. This can lead to a poor treatment response and a worse patient prognosis. One of the hypoxia-responsive genes is aspartate-β-hydroxylase (ASPH), whose activity promotes the growth, invasiveness, and metastasis of many types of solid tumors.
METHODS
METHODS
In our study, HNSCC samples were analyzed for the expression of ASPH and selected endogenous hypoxia markers by real-time PCR and/or multiplex fluorescence immunohistochemistry.
RESULTS
RESULTS
Except for the EPAS1 gene, which had higher mRNA expression in the HPV-negative group of HNSCC (p < 0.05), we found no other differences in the expression of the tested genes that were related to HPV status. On the contrary, a statistically significantly higher number of cells producing ASPH (p < 0.0001), HIF1A (p < 0.0001), GLUT1 (p < 0.0001), and MMP13 (p < 0.05) proteins were detected in the HPV-positive tumor group than in the HPV-negative sample group. All the evaluated markers, except for MMP9/13, were more abundant in the tumor parenchyma than in the tumor stroma. The Cox proportional hazard models showed that increased numbers of cells with GLUT1 and HIF1A protein expression were positive prognostic markers for overall and disease-specific survival in patients independent of HPV tumor status.
CONCLUSION
CONCLUSIONS
The study examined HNSCC samples and found that elevated ASPH and hypoxia marker proteins, typically associated with poor prognosis, may actually indicate active HPV infection, the strongest prognostic factor in HNSCC patients. In cases where HPV status is uncertain, increased expression of HIF1A and GLUT1 can serve as positive prognostic factors.
Identifiants
pubmed: 38858774
doi: 10.1186/s13027-024-00588-1
pii: 10.1186/s13027-024-00588-1
doi:
Types de publication
Journal Article
Langues
eng
Pagination
26Subventions
Organisme : Ministry of Education, Youth and Sports, Czech Republic
ID : Inter-Excellence programme (No. LTAUSA18003)
Organisme : European Union - Next Generation EU
ID : Programme EXCELES, ID Project No. LX22NPO5103
Organisme : Charles University, Prague, Czech Republic
ID : SVV260679
Informations de copyright
© 2024. The Author(s).
Références
Wittekindt C, Wagner S, Sharma SJ, Würdemann N, Knuth J, Reder H, et al. HPV – a different view on Head and Neck Cancer. Laryngorhinootologie. 2018;97(Suppl 1):S48–113.
pubmed: 29905354
pmcid: 6540966
Göttgens E-L, Ostheimer C, Span PN, Bussink J, Hammond EM. HPV, hypoxia and radiation response in head and neck cancer. Br J Radiol. 2019;92:20180047.
pubmed: 29493265
Almangush A, Jouhi L, Atula T, Haglund C, Mäkitie AA, Hagström J, et al. Tumour-infiltrating lymphocytes in oropharyngeal cancer: a validation study according to the criteria of the International Immuno-Oncology Biomarker Working Group. Br J Cancer. 2022;126:1589–94.
pubmed: 35043007
pmcid: 9130301
doi: 10.1038/s41416-022-01708-7
Bisheshar SK, van der Kamp MF, de Ruiter EJ, Ruiter LN, van der Vegt B, Breimer GE, et al. The prognostic role of tumor associated macrophages in squamous cell carcinoma of the head and neck: a systematic review and meta-analysis. Oral Oncol. 2022;135:106227.
pubmed: 36335818
doi: 10.1016/j.oraloncology.2022.106227
Pokrývková B, Grega M, Klozar J, Vencálek O, Nunvář J, Tachezy R. PD1 + CD8 + cells are an independent prognostic marker in patients with Head and Neck Cancer. Biomedicines. 2022;10:2794.
pubmed: 36359314
pmcid: 9687997
doi: 10.3390/biomedicines10112794
Semenza GL. HIF-1 and mechanisms of hypoxia sensing. Curr Opin Cell Biol. 2001;13:167–71.
pubmed: 11248550
doi: 10.1016/S0955-0674(00)00194-0
Maxwell PH, Pugh CW, Ratcliffe PJ. Activation of the HIF pathway in cancer. Curr Opin Genet Dev. 2001;11:293–9.
pubmed: 11377966
doi: 10.1016/S0959-437X(00)00193-3
Multhoff G, Vaupel P. Hypoxia compromises Anti-cancer Immune responses. Adv Exp Med Biol. 2020;1232:131–43.
pubmed: 31893404
doi: 10.1007/978-3-030-34461-0_18
Swartz JE, Pothen AJ, van Kempen PMW, Stegeman I, Formsma FK, Cann EMV, et al. Poor prognosis in human papillomavirus-positive oropharyngeal squamous cell carcinomas that overexpress hypoxia inducible factor-1α. Head Neck. 2016;38:1338–46.
pubmed: 27027530
doi: 10.1002/hed.24445
Hong A, Zhang M, Veillard A-S, Jahanbani J, Lee CS, Jones D, et al. The prognostic significance of hypoxia inducing factor 1-α in oropharyngeal cancer in relation to human papillomavirus status. Oral Oncol. 2013;49:354–9.
pubmed: 23266008
doi: 10.1016/j.oraloncology.2012.11.006
Toustrup K, Sørensen BS, Alsner J, Overgaard J. Hypoxia Gene Expression Signatures as prognostic and predictive markers in Head and Neck Radiotherapy. Semin Radiat Oncol. 2012;22:119–27.
pubmed: 22385919
doi: 10.1016/j.semradonc.2011.12.006
Deschuymer S, Sørensen BS, Dok R, Laenen A, Hauben E, Overgaard J, et al. Prognostic value of a 15-gene hypoxia classifier in oropharyngeal cancer treated with accelerated chemoradiotherapy. Strahlenther Onkol. 2020;196:552–60.
pubmed: 32080773
doi: 10.1007/s00066-020-01595-y
Nakamura M, Bodily JM, Beglin M, Kyo S, Inoue M, Laimins LA. Hypoxia-specific stabilization of HIF-1alpha by human papillomaviruses. Virology. 2009;387:442–8.
pubmed: 19321184
doi: 10.1016/j.virol.2009.02.036
Bodily JM, Mehta KPM, Laimins LA. Human papillomavirus E7 enhances hypoxia-inducible factor 1-mediated transcription by inhibiting binding of histone deacetylases. Cancer Res. 2011;71:1187–95.
pubmed: 21148070
doi: 10.1158/0008-5472.CAN-10-2626
Guo Y, Meng X, Ma J, Zheng Y, Wang Q, Wang Y, et al. Human papillomavirus 16 E6 contributes HIF-1α induced Warburg effect by attenuating the VHL-HIF-1α interaction. Int J Mol Sci. 2014;15:7974–86.
pubmed: 24810689
pmcid: 4057713
doi: 10.3390/ijms15057974
Knuth J, Sharma SJ, Würdemann N, Holler C, Garvalov BK, Acker T, et al. Hypoxia-inducible factor-1α activation in HPV-positive head and neck squamous cell carcinoma cell lines. Oncotarget. 2017;8:89681–91.
pubmed: 29163780
pmcid: 5685701
doi: 10.18632/oncotarget.20813
Bredell MG, Ernst J, El-Kochairi I, Dahlem Y, Ikenberg K, Schumann DM. Current relevance of hypoxia in head and neck cancer. Oncotarget. 2016;7:50781–804.
pubmed: 27434126
pmcid: 5226620
doi: 10.18632/oncotarget.9549
Wegge M, Dok R, Nuyts S. Hypoxia and its influence on Radiotherapy response of HPV-Positive and HPV-Negative Head and Neck Cancer. Cancers (Basel). 2021;13:5959.
pubmed: 34885069
doi: 10.3390/cancers13235959
Ince N, Monte SM, de la, Wands JR. Overexpression of human aspartyl (asparaginyl) β-Hydroxylase is Associated with Malignant Transformation. Cancer Res. 2000;60:1261–6.
pubmed: 10728685
Kanwal M, Smahel M, Olsen M, Smahelova J, Tachezy R. Aspartate β-hydroxylase as a target for cancer therapy. J Exp Clin Cancer Res. 2020;39:163.
pubmed: 32811566
pmcid: 7433162
doi: 10.1186/s13046-020-01669-w
Pokrývková B, Šmahelová J, Dalewská N, Grega M, Vencálek O, Šmahel M, et al. ARG1 mRNA level is a promising prognostic marker in Head and Neck squamous cell carcinomas. Diagnostics (Basel). 2021;11:628.
pubmed: 33807310
doi: 10.3390/diagnostics11040628
Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The Eighth Edition AJCC Cancer staging Manual: continuing to build a bridge from a population-based to a more personalized approach to cancer staging. CA Cancer J Clin. 2017;67:93–9.
pubmed: 28094848
doi: 10.3322/caac.21388
Tachezy R, Smahelova J, Salakova M, Arbyn M, Rob L, Skapa P, et al. Human papillomavirus genotype distribution in Czech women and men with diseases etiologically linked to HPV. PLoS ONE. 2011;6:e21913.
pubmed: 21765924
pmcid: 3135602
doi: 10.1371/journal.pone.0021913
Rotnáglová E, Tachezy R, Saláková M, Procházka B, Košl’abová E, Veselá E, et al. HPV involvement in tonsillar cancer: prognostic significance and clinically relevant markers. Int J Cancer. 2011;129:101–10.
pubmed: 21190188
doi: 10.1002/ijc.25889
Chang WH, Forde D, Lai AG. Dual prognostic role of 2-oxoglutarate-dependent oxygenases in ten cancer types: implications for cell cycle regulation and cell adhesion maintenance. Cancer Commun (Lond). 2019;39:23.
pubmed: 31036064
Hou G, Xu B, Bi Y, Wu C, Ru B, Sun B, et al. Recent advances in research on aspartate β-hydroxylase (ASPH) in pancreatic cancer: a brief update. Bosn J Basic Med Sci. 2018;18:297–304.
pubmed: 30179586
pmcid: 6252103
doi: 10.17305/bjbms.2018.3539
Henken FE, Banerjee NS, Snijders PJF, Meijer CJLM, De-Castro Arce J, Rösl F, et al. PIK3CA-mediated PI3-kinase signalling is essential for HPV-induced transformation in vitro. Mol Cancer. 2011;10:71.
pubmed: 21663621
pmcid: 3130697
doi: 10.1186/1476-4598-10-71
Lawton M, Tong M, Gundogan F, Wands JR, de la Monte SM. Aspartyl-(asparaginyl) β-Hydroxylase, Hypoxia-Inducible Factor-1α and notch cross-talk in regulating neuronal motility. Oxid Med Cell Longev. 2010;3:347–56.
pubmed: 21150341
pmcid: 3154035
doi: 10.4161/oxim.3.5.13296
Vogel C, Marcotte EM. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet. 2012;13:227–32.
pubmed: 22411467
pmcid: 3654667
doi: 10.1038/nrg3185
Edfors F, Danielsson F, Hallström BM, Käll L, Lundberg E, Pontén F, et al. Gene-specific correlation of RNA and protein levels in human cells and tissues. Mol Syst Biol. 2016;12:883.
pubmed: 27951527
pmcid: 5081484
doi: 10.15252/msb.20167144
Chee NT, Lohse I, Brothers SP. mRNA-to-protein translation in hypoxia. Mol Cancer. 2019;18:49.
pubmed: 30925920
pmcid: 6441220
doi: 10.1186/s12943-019-0968-4
Bachtiary B, Schindl M, Pötter R, Dreier B, Knocke TH, Hainfellner JA, et al. Overexpression of Hypoxia-inducible factor 1α indicates diminished response to Radiotherapy and unfavorable prognosis in patients receiving Radical Radiotherapy for cervical Cancer1. Clin Cancer Res. 2003;9:2234–40.
pubmed: 12796391
Tang J-Y, Li D-Y, He L, Qiu X-S, Wang E-H, Wu G-P. HPV 16 E6/E7 promote the glucose uptake of GLUT1 in Lung Cancer through downregulation of TXNIP due to inhibition of PTEN Phosphorylation. Front Oncol. 2020;10.
Priego-Hernández VD, Arizmendi-Izazaga A, Soto-Flores DG, Santiago-Ramón N, Feria-Valadez MD, Navarro-Tito N, et al. Expression of HIF-1α and genes involved in glucose metabolism is increased in Cervical Cancer and HPV-16-Positive cell lines. Pathogens. 2023;12:33.
doi: 10.3390/pathogens12010033
Kappler M, Pabst U, Rot S, Taubert H, Wichmann H, Schubert J, et al. Normoxic accumulation of HIF1α is associated with glutaminolysis. Clin Oral Investig. 2017;21:211–24.
pubmed: 26955835
doi: 10.1007/s00784-016-1780-9
Rodolico V, Arancio W, Amato MC, Aragona F, Cappello F, Di Fede O, et al. Hypoxia inducible factor-1 alpha expression is increased in infected positive HPV16 DNA oral squamous cell carcinoma and positively associated with HPV16 E7 oncoprotein. Infect Agent Cancer. 2011;6:18.
pubmed: 22032288
pmcid: 3213191
doi: 10.1186/1750-9378-6-18
Fei J, Hong A, Dobbins TA, Jones D, Soon Lee C, Loo C, et al. Prognostic significance of vascular endothelial growth factor in squamous cell carcinomas of the Tonsil in relation to human papillomavirus status and epidermal growth factor receptor. Ann Surg Oncol. 2009;16:2908–17.
pubmed: 19603236
doi: 10.1245/s10434-009-0579-1
Ang KK, Sturgis EM. Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma. Semin Radiat Oncol. 2012;22:128–42.
pubmed: 22385920
doi: 10.1016/j.semradonc.2011.12.004
Gong L, Zhang W, Zhou J, Lu J, Xiong H, Shi X, et al. Prognostic value of HIFs expression in head and neck cancer: a systematic review. PLoS ONE. 2013;8:e75094.
pubmed: 24058651
pmcid: 3772872
doi: 10.1371/journal.pone.0075094
Beasley NJP, Leek R, Alam M, Turley H, Cox GJ, Gatter K, et al. Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients. Cancer Res. 2002;62:2493–7.
pubmed: 11980639
Fillies T, Werkmeister R, van Diest PJ, Brandt B, Joos U, Buerger H. HIF1-alpha overexpression indicates a good prognosis in early stage squamous cell carcinomas of the oral floor. BMC Cancer. 2005;5:84.
pubmed: 16035955
pmcid: 1190162
doi: 10.1186/1471-2407-5-84
Li C-X, Sun J-L, Gong Z-C, Lin Z-Q, Liu H. Prognostic value of GLUT-1 expression in oral squamous cell carcinoma. Med (Baltim). 2016;95:e5324.
doi: 10.1097/MD.0000000000005324
Wang J, Ye C, Chen C, Xiong H, Xie B, Zhou J, et al. Glucose transporter GLUT1 expression and clinical outcome in solid tumors: a systematic review and meta-analysis. Oncotarget. 2017;8:16875–86.
pubmed: 28187435
pmcid: 5370007
doi: 10.18632/oncotarget.15171
Sitarz K, Czamara K, Szostek S, Kaczor A. The impact of HPV infection on human glycogen and lipid metabolism – a review. Biochim et Biophys Acta (BBA) - Reviews Cancer. 2022;1877:188646.
doi: 10.1016/j.bbcan.2021.188646
Fan R, Hou W-J, Zhao Y-J, Liu S-L, Qiu X-S, Wang E-H, et al. Overexpression of HPV16 E6/E7 mediated HIF-1α upregulation of GLUT1 expression in lung cancer cells. Tumour Biol. 2016;37:4655–63.
pubmed: 26508030
doi: 10.1007/s13277-015-4221-5
Fang J, Li X, Ma D, Liu X, Chen Y, Wang Y, et al. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma. BMC Cancer. 2017;17:375.
pubmed: 28549420
pmcid: 5446725
doi: 10.1186/s12885-017-3317-2
Höing B, Kanaan O, Altenhoff P, Petri R, Thangavelu K, Schlüter A, et al. Stromal versus tumoral inflammation differentially contribute to metastasis and poor survival in laryngeal squamous cell carcinoma. Oncotarget. 2018;9:8415–26.
pubmed: 29492204
pmcid: 5823564
doi: 10.18632/oncotarget.23865
Mendonça F, Teles AM, Nascimento MDDSB, Santos APAD, Lopes FF, Paiva A, et al. Human papillomavirus modulates Matrix metalloproteinases during carcinogenesis: clinical significance and role of viral oncoproteins. Vivo. 2022;36:2531–41.
doi: 10.21873/invivo.12990
Alkharsah KR. VEGF upregulation in viral infections and its possible therapeutic implications. Int J Mol Sci. 2018;19:1642.
pubmed: 29865171
pmcid: 6032371
doi: 10.3390/ijms19061642
Jo S, Juhasz A, Zhang K, Ruel C, Loera S, Wilczynski SP, et al. Human papillomavirus infection as a prognostic factor in Oropharyngeal Squamous Cell Carcinomas Treated in a prospective phase II clinical trial. Anticancer Res. 2009;29:1467–74.
pubmed: 19443352
pmcid: 3582681
Karpathiou G, Stachowitz M-L, Dumollard JM, Gavid M, Froudarakis M, Prades JM, et al. Gene Expression Comparison between the Primary Tumor and its Lymph Node Metastasis in Head and Neck squamous cell carcinoma: a pilot study. Cancer Genomics Proteomics. 2019;16:155–61.
pubmed: 31018946
pmcid: 6542642
doi: 10.21873/cgp.20121
Baruah P, Lee M, Wilson POG, Odutoye T, Williamson P, Hyde N, et al. Impact of p16 status on pro- and anti-angiogenesis factors in head and neck cancers. Br J Cancer. 2015;113:653–9.
pubmed: 26171937
pmcid: 4647678
doi: 10.1038/bjc.2015.251
Troy JD, Weissfeld JL, Youk AO, Thomas S, Wang L, Grandis JR. Expression of EGFR, VEGF, and NOTCH1 suggest differences in Tumor Angiogenesis in HPV-Positive and HPV-Negative Head and Neck squamous cell carcinoma. Head Neck Pathol. 2013;7:344–55.
pubmed: 23645351
pmcid: 3824798
doi: 10.1007/s12105-013-0447-y
Kyzas PA, Stefanou D, Batistatou A, Agnantis NJ. Prognostic significance of VEGF immunohistochemical expression and tumor angiogenesis in head and neck squamous cell carcinoma. J Cancer Res Clin Oncol. 2005;131:624–30.
pubmed: 16044346
doi: 10.1007/s00432-005-0003-6
Tse GM, Chan AWH, Yu K-H, King AD, Wong K-T, Chen GG, et al. Strong immunohistochemical expression of vascular endothelial growth factor predicts overall survival in Head and Neck squamous cell carcinoma. Ann Surg Oncol. 2007;14:3558–65.
pubmed: 17929099
doi: 10.1245/s10434-007-9632-0